Literature DB >> 17686632

Inhibition of carcinogenesis by tea constituents.

Jihyeung Ju1, Gang Lu, Joshua D Lambert, Chung S Yang.   

Abstract

The possible cancer preventive activity of tea has received much attention in recent years. The inhibitory activities of tea and tea constituents against carcinogenesis at different organ sites have been demonstrated in many animal models. The effect of tea consumption on human cancers, however, remains inconclusive. The mechanisms of action of tea polyphenols, especially EGCG, the most abundant and active catechin, have been extensively investigated. Most of the studies, however, were based on cell culture systems, and these mechanisms need to be evaluated and verified in animal models or humans in order to gain more understanding on the effect of tea consumption on human cancer. Human intervention trials are warranted to determine the possible prevention of cancer of specific sites by preparation of tea constituents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17686632      PMCID: PMC2736048          DOI: 10.1016/j.semcancer.2007.06.013

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  86 in total

Review 1.  Tea and prostate cancer.

Authors:  S K Chhabra; C S Yang
Journal:  Epidemiol Rev       Date:  2001       Impact factor: 6.222

2.  Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression.

Authors:  M J Wargovich; A Jimenez; K McKee; V E Steele; M Velasco; J Woods; R Price; K Gray; G J Kelloff
Journal:  Carcinogenesis       Date:  2000-06       Impact factor: 4.944

3.  Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo.

Authors:  S Nam; D M Smith; Q P Dou
Journal:  J Biol Chem       Date:  2001-01-26       Impact factor: 5.157

4.  A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin.

Authors:  Z Zhang; Q Liu; L E Lantry; Y Wang; G J Kelloff; M W Anderson; R W Wiseman; R A Lubet; M You
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

5.  Inhibitory effects of orally administered green tea, black tea, and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high-risk mice): relationship to decreased tissue fat.

Authors:  Y P Lu; Y R Lou; Y Lin; W J Shih; M T Huang; C S Yang; A H Conney
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

6.  Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice.

Authors:  M Suganuma; Y Ohkura; S Okabe; H Fujiki
Journal:  J Cancer Res Clin Oncol       Date:  2001-01       Impact factor: 4.553

Review 7.  Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer.

Authors:  M D Brown
Journal:  Altern Med Rev       Date:  1999-10

8.  (-)-Epigallocatechin gallate can prevent cisplatin-induced lung tumorigenesis in A/J mice.

Authors:  J Mimoto; K Kiura; K Matsuo; T Yoshino; I Takata; H Ueoka; M Kataoka; M Harada
Journal:  Carcinogenesis       Date:  2000-05       Impact factor: 4.944

9.  Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols.

Authors:  S Gupta; K Hastak; N Ahmad; J S Lewin; H Mukhtar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

10.  Effects of black tea, green tea and wine extracts on intestinal carcinogenesis induced by azoxymethane in F344 rats.

Authors:  G Caderni; C De Filippo; C Luceri; M Salvadori; A Giannini; A Biggeri; S Remy; V Cheynier; P Dolara
Journal:  Carcinogenesis       Date:  2000-11       Impact factor: 4.944

View more
  36 in total

1.  Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus.

Authors:  Andrew K Joe; Felice Schnoll-Sussman; Robert S Bresalier; Julian A Abrams; Hanina Hibshoosh; Ken Cheung; Richard A Friedman; Chung S Yang; Ginger L Milne; Diane D Liu; J Jack Lee; Kazeem Abdul; Michelle Bigg; Jessica Foreman; Tao Su; Xiaomei Wang; Aqeel Ahmed; Alfred I Neugut; Esther Akpa; Scott M Lippman; Marjorie Perloff; Powel H Brown; Charles J Lightdale
Journal:  Cancer Prev Res (Phila)       Date:  2015-10-15

2.  Green tea and PUMA: a deadly combination?

Authors:  Crissy Dudgeon; Jian Yu
Journal:  Cancer Biol Ther       Date:  2008-05-21       Impact factor: 4.742

3.  Green tea and liver cancer.

Authors:  Francesca Bravi; Carlo La Vecchia; Federica Turati
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

Review 4.  Tea Consumption and Risk of Cancer: An Umbrella Review and Meta-Analysis of Observational Studies.

Authors:  Tai Lim Kim; Gwang Hun Jeong; Jae Won Yang; Keum Hwa Lee; Andreas Kronbichler; Hans J van der Vliet; Giuseppe Grosso; Fabio Galvano; Dagfinn Aune; Jong Yeob Kim; Nicola Veronese; Brendon Stubbs; Marco Solmi; Ai Koyanagi; Sung Hwi Hong; Elena Dragioti; Eunyoung Cho; Leandro F M de Rezende; Edward L Giovannucci; Jae Il Shin; Gabriele Gamerith
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

5.  A preliminary investigation of the impact of catechol-O-methyltransferase genotype on the absorption and metabolism of green tea catechins.

Authors:  Rosalind J Miller; Kim G Jackson; Tony Dadd; Beate Nicol; Joanne L Dick; Andrew E Mayes; A Louise Brown; Anne M Minihane
Journal:  Eur J Nutr       Date:  2011-03-29       Impact factor: 5.614

6.  Prospective cohort study of tea consumption and risk of digestive system cancers: results from the Shanghai Women's Health Study.

Authors:  Sarah Nechuta; Xiao-Ou Shu; Hong-Lan Li; Gong Yang; Bu-Tian Ji; Yong-Bing Xiang; Hui Cai; Wong-Ho Chow; Yu-Tang Gao; Wei Zheng
Journal:  Am J Clin Nutr       Date:  2012-10-10       Impact factor: 7.045

Review 7.  Treatment of inflammatory bowel disease via green tea polyphenols: possible application and protective approaches.

Authors:  Sajid Ur Rahman; Yu Li; Yingying Huang; Lei Zhu; Shibin Feng; Jinjie Wu; Xichun Wang
Journal:  Inflammopharmacology       Date:  2018-03-12       Impact factor: 4.473

8.  (-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial-mesenchymal transition via NF-κB p65 inactivation.

Authors:  Ya-Jun Li; Shun-Long Wu; Song-Mei Lu; Fang Chen; Ying Guo; Sheng-Min Gan; Yan-Long Shi; Shuang Liu; Shao-Lin Li
Journal:  Tumour Biol       Date:  2014-12-07

9.  Is green tea drinking associated with a later onset of breast cancer?

Authors:  Qi Dai; Xiao-Ou Shu; Honglan Li; Gong Yang; Martha J Shrubsole; Hui Cai; Butian Ji; Wanqing Wen; Adrian Franke; Yu-Tang Gao; Wei Zheng
Journal:  Ann Epidemiol       Date:  2010-01       Impact factor: 3.797

10.  Coffee, tea, caffeine intake, and risk of adult glioma in three prospective cohort studies.

Authors:  Crystal N Holick; Scott G Smith; Edward Giovannucci; Dominique S Michaud
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.